Variant NKX3.1 and Serum IGF-1: Investigation of Interaction in Prostate Cancer

Genes and Cancer - United States
doi 10.1177/1947601913506009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Interaction of NKX3.1 and SELENOP Genotype With Prostate Cancer Recurrence

Prostate
OncologyUrology
2018English

Serum IGF-1 Determination in Relation to Prostate Cancer Screening: Possible Differential Diagnosis in Relation to PSA Assays

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2000English

Plasma Androgens, IGF-1, Body Size, and Prostate Cancer Risk: A Synthetic Review

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2000English

Anti-Tumor Activity of the IGF-1/IGF-2-Neutralizing Antibody Xentuzumab (BI 836845) in Combination With Enzalutamide in Prostate Cancer Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2020English

CORRELATION OF SERUM ^|^gamma;-Seminoprotein AND SERUM PROSTATE-SPECIFIC ANTIGEN IN PATIENTS WITH PROSTATE CANCER

Japanese Journal of Urology
Urology
1989English

Serum Oxidized Protein and Prostate Cancer Risk Within the Prostate Cancer Prevention Trial

Cancer Prevention Research
MedicineCancer ResearchOncology
2010English

Serum Insulin Like Growth Factor (IGF-1) and Leptin Levels in Osteosarcoma

American Journal of Biochemistry and Molecular Biology
BiochemistryGeneticsMolecular Biology
2014English

Clinicopathologic Diagnostic Approach to Aggressive Variant Prostate Cancer

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2020English

IGF-1 Is Downregulated in Experimental Cancer Cachexia

American Journal of Physiology - Regulatory Integrative and Comparative Physiology
Physiology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy